Stable and High-Producing CHO Cell Expression System with Broad Compatibility
Original License
Official authorization from ECACC (European Collection of Authenticated Cell Cultures)under Public Health England, where global rights are held by the European branch of Canton Biologics
Endorsement by Leading Companies
Widely adopted by global leading enterprises such as Zoetis(formerly Pfizer Animal Health), Novo Nordisk, and Regeneron
Stable and High-Producing
Batch yield up to 39g/L, with outstanding large-scale scaling -up capability
Product Family
Multiple modified lines such as CHO K1 wild-type, GS-knockout, and fucose-knockout
Broad Compatibility
Excellently expresses various products such as monoclonal antibodies, bispecific antibodies, and recombinant proteins
中文
